Tumescent Anesthesia Antibiotic Delivery (TAAD)

Clinical trial NCT03226626 · UNKNOWN

Trial details

NCT number: NCT03226626
Sponsor: HK Surgical, Inc.
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Surgical Site Infection Thrombosis Sepsis

Start date: 2021-12-01
Primary completion: 2022-01-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.